[HTML][HTML] Two Approaches to Triple Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Treated with Percutaneous …
W Bachorski, J Bychowski, M Gruchała, M Jaguszewski - Diagnostics, 2023 - mdpi.com
Introduction: Patients with acute coronary syndrome (ACS) and atrial fibrillation (AF) treated
with percutaneous coronary intervention (PCI) are at high risk of bleeding and …
with percutaneous coronary intervention (PCI) are at high risk of bleeding and …
[HTML][HTML] Two Approaches to Triple Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Treated with Percutaneous …
W Bachorski, J Bychowski, M Gruchała… - Diagnostics, 2023 - ncbi.nlm.nih.gov
Introduction: Patients with acute coronary syndrome (ACS) and atrial fibrillation (AF) treated
with percutaneous coronary intervention (PCI) are at high risk of bleeding and …
with percutaneous coronary intervention (PCI) are at high risk of bleeding and …
Two Approaches to Triple Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Treated with Percutaneous Coronary …
W Bachorski, J Bychowski, M Gruchała… - …, 2023 - search.proquest.com
Introduction: Patients with acute coronary syndrome (ACS) and atrial fibrillation (AF) treated
with percutaneous coronary intervention (PCI) are at high risk of bleeding and …
with percutaneous coronary intervention (PCI) are at high risk of bleeding and …
Two Approaches to Triple Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Treated with Percutaneous Coronary …
W Bachorski, J Bychowski, M Gruchała… - Diagnostics (Basel …, 2023 - europepmc.org
Methods This was a retrospective, single-center study based on all consecutive patients with
the diagnosis of ACS and AF treated with vitamin K antagonists (VKA) or non-vitamin K …
the diagnosis of ACS and AF treated with vitamin K antagonists (VKA) or non-vitamin K …
Two Approaches to Triple Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Treated with Percutaneous Coronary …
W Bachorski, J Bychowski… - Diagnostics (Basel …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Patients with acute coronary syndrome (ACS) and atrial fibrillation (AF) treated
with percutaneous coronary intervention (PCI) are at high risk of bleeding and …
with percutaneous coronary intervention (PCI) are at high risk of bleeding and …
[PDF][PDF] Two Approaches to Triple Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Treated with Percutaneous …
W Bachorski, J Bychowski, M Gruchała, M Jaguszewski - 2023 - ppm.edu.pl
Introduction: Patients with acute coronary syndrome (ACS) and atrial fibrillation (AF) treated
with percutaneous coronary intervention (PCI) are at high risk of bleeding and …
with percutaneous coronary intervention (PCI) are at high risk of bleeding and …
Two Approaches to Triple Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Treated with Percutaneous Coronary …
W Bachorski, J Bychowski, M Gruchała… - Diagnostics (2075 …, 2023 - search.ebscohost.com
Introduction: Patients with acute coronary syndrome (ACS) and atrial fibrillation (AF) treated
with percutaneous coronary intervention (PCI) are at high risk of bleeding and …
with percutaneous coronary intervention (PCI) are at high risk of bleeding and …
Two Approaches to Triple Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Treated with Percutaneous Coronary …
W Bachorski, J Bychowski, M Gruchała… - Diagnostics (Basel …, 2023 - europepmc.org
Methods This was a retrospective, single-center study based on all consecutive patients with
the diagnosis of ACS and AF treated with vitamin K antagonists (VKA) or non-vitamin K …
the diagnosis of ACS and AF treated with vitamin K antagonists (VKA) or non-vitamin K …